V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210033093 | 210010196 | 1.72 | 29 | Disease modification (D) | 2016-12-30 | 2017-02-08 | Temozolomide + RT | N | null | 210021343 | TEMOZOLOMIDE + RT |
| 210033094 | 210010205 | null | 84.7 | Palliative (P) | 2017-09-30 | 2017-09-30 | Trial Unspecified | 1 | null | 210021363 | TRIAL |
| 210033095 | 210010209 | 1.75 | 67.1 | Curative (C) | 2015-09-03 | 2015-10-01 | Temozolomide + RT | N | null | 210021386 | TEMOZOLOMIDE + RT |
| 210033096 | 210010214 | 1.72 | 38.6 | Palliative (P) | 2016-01-08 | 2016-02-08 | Temozolomide + RT | null | N | 210021410 | TEMOZOLOMIDE + RT |
| 210033097 | 210010218 | 1.74 | 0 | Disease modification (D) | 2017-10-07 | 2017-10-23 | Trial Unspecified | N | N | 210021415 | TRIAL |
| 210033098 | 210010232 | 0 | null | Disease modification (D) | 2015-08-30 | 2015-10-31 | Temozolomide + RT | N | N | 210021499 | TEMOZOLOMIDE + RT |
| 210033099 | 210010234 | 1.86 | 68.5 | Disease modification (D) | 2018-09-01 | 2018-11-24 | Trial Unspecified | 01 | N | 210021507 | TRIAL |
| 210033100 | 210010236 | 1.81 | 53 | Curative (C) | 2013-07-05 | 2013-10-12 | Trial Unspecified | 1 | N | 210021509 | TRIAL |
| 210033101 | 210010238 | null | 76.4 | Disease modification (D) | 2018-05-08 | 2018-05-29 | Temozolomide + RT | N | N | 210021523 | TEMOZOLOMIDE + RT |
| 210033102 | 210010247 | 1.75 | 77.3 | Disease modification (D) | 2017-01-31 | 2017-05-25 | Trial Unspecified | N | N | 210021548 | TRIAL |
| 210033103 | 210020598 | 1.52 | 67.6 | Palliative (P) | 2017-04-11 | 2017-05-12 | Temozolomide + RT | N | N | 210021573 | TEMOZOLOMIDE + RT |
| 210033104 | 210010253 | null | null | null | 2015-05-12 | 2015-08-05 | Trial Unspecified | N | N | 210021577 | TRIAL |
| 210033105 | 210027098 | null | 63.7 | Curative (C) | 2015-01-27 | 2015-03-07 | Temozolomide + RT | N | null | 210021581 | TEMOZOLOMIDE + RT |
| 210033106 | 210027098 | null | null | Curative (C) | 2018-07-03 | 2018-07-31 | Temozolomide + RT | 2 | N | 210021581 | TEMOZOLOMIDE + RT |
| 210033107 | 210027099 | 1.04 | 85.9 | Adjuvant (A) | null | 2016-01-21 | Trial Unspecified | N | N | 210021599 | TRIAL |
| 210033108 | 210027099 | 1.16 | 109.6 | Curative (C) | null | 2015-05-02 | Temozolomide + RT | N | N | 210021599 | TEMOZOLOMIDE + RT |
| 210033109 | 210010261 | null | 69.3 | Curative (C) | 2014-04-29 | 2014-05-04 | Trial Unspecified | null | null | 210021626 | TRIAL |
| 210033110 | 210010275 | null | 86.4 | Palliative (P) | null | 2014-04-04 | Trial Unspecified | Y | N | 210021729 | TRIAL |
| 210033111 | 210010296 | 1.63 | 20.6 | Curative (C) | 2017-04-30 | 2018-03-31 | Trial Unspecified | Y | N | 210021799 | TRIAL |
| 210033112 | 210010302 | null | 91.8 | Curative (C) | 2016-02-22 | 2016-02-26 | Temozolomide + RT | 2 | N | 210021830 | TEMOZOLOMIDE + RT |
| 210033113 | 210010321 | 1.77 | 76.2 | Curative (C) | null | 2016-03-15 | Temozolomide + RT | N | null | 210021882 | TEMOZOLOMIDE + RT |
| 210033114 | 210010330 | 1.8 | 81 | Palliative (P) | 2015-10-19 | 2015-10-22 | Lomustine | N | N | 210021937 | LOMUSTINE |
| 210033115 | 210027115 | 1.52 | 89 | Palliative (P) | null | 2018-04-02 | Lomustine | N | N | 210021949 | LOMUSTINE |
| 210033116 | 210010345 | 1.73 | 62.2 | Palliative (P) | null | 2014-05-23 | Lomustine | N | N | 210022005 | LOMUSTINE |
| 210033117 | 210020679 | 1.66 | 78.1 | Adjuvant (A) | 2012-11-03 | 2015-11-07 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 210022026 | RITUXIMAB |
| 210033118 | 210010354 | 0 | 97.65 | Adjuvant (A) | 2017-06-18 | 2018-07-08 | IBRUTINIB | 2 | N | 210022042 | IBRUTINIB |
| 210033119 | 210010362 | null | 101 | Palliative (P) | 2015-07-18 | 2015-07-28 | Rituximab | 02 | N | 210022063 | RITUXIMAB |
| 210033120 | 210010368 | 1.44 | 62.3 | Disease modification (D) | 2016-01-03 | 2016-02-16 | IBRUTINIB | 2 | N | 210022107 | IBRUTINIB |
| 210033121 | 210010377 | null | 97.4 | Palliative (P) | 2016-04-12 | 2016-07-18 | Rituximab | 02 | N | 210022156 | RITUXIMAB |
| 210033122 | 210010386 | 1.75 | null | Palliative (P) | 2015-05-14 | 2015-05-14 | Lomustine | N | N | 210022224 | LOMUSTINE |
| 210033123 | 210010389 | 1.77 | null | Adjuvant (A) | 2018-11-13 | 2018-11-13 | IBRUTINIB | N | N | 210022230 | IBRUTINIB |
| 210033124 | 210020719 | null | 98.2 | Palliative (P) | null | 2019-04-09 | IBRUTINIB | N | Y | 210022299 | IBRUTINIB |
| 210033125 | 210010404 | 1.7 | 62.2 | Adjuvant (A) | 2015-04-12 | 2015-04-12 | Rituximab | N | N | 210022448 | RITUXIMAB |
| 210033126 | 210020732 | 1.67 | 85 | Palliative (P) | 2016-05-23 | 2016-05-23 | IBRUTINIB | N | N | 210022614 | IBRUTINIB |
| 210033127 | 210010418 | 1.59 | 48 | Adjuvant (A) | 2018-09-11 | 2018-09-11 | IBRUTINIB | N | N | 210022620 | IBRUTINIB |
| 210033128 | 210030960 | 1.6 | 63.2 | Palliative (P) | 2018-07-12 | 2019-07-23 | Lomustine | 02 | N | 210022624 | LOMUSTINE |
| 210033129 | 210010445 | 1.49 | 93.5 | null | 2016-02-17 | 2016-02-24 | Rituximab | 02 | N | 210022961 | RITUXIMAB |
| 210033130 | 210010449 | 1.8 | 54 | Curative (C) | 2017-12-01 | 2017-12-01 | IBRUTINIB | 02 | N | 210023044 | IBRUTINIB |
| 210033131 | 210020761 | 1.79 | 92.7 | Palliative (P) | null | 2017-01-10 | Lomustine | N | N | 210023048 | LOMUSTINE |
| 210033132 | 210010455 | 1.8 | 84.2 | Palliative (P) | 2017-10-27 | 2017-10-27 | IBRUTINIB | 02 | N | 210023081 | IBRUTINIB |
| 210033133 | 210020771 | null | 75 | Adjuvant (A) | 2016-04-18 | 2016-05-01 | Rituximab | 02 | N | 210023222 | RITUXIMAB |
| 210033134 | 210010467 | 1.64 | 98.8 | Palliative (P) | 2015-07-15 | 2015-08-01 | IBRUTINIB | 02 | N | 210023251 | IBRUTINIB |
| 210033135 | 210010472 | null | null | Palliative (P) | 2018-07-09 | 2018-07-09 | Lomustine | N | null | 210023274 | LOMUSTINE |
| 210033136 | 210010485 | 1.54 | 70.4 | Adjuvant (A) | 2017-12-25 | 2018-03-27 | Rituximab | N | N | 210023346 | RITUXIMAB |
| 210033137 | 210010493 | 1.72 | 58.4 | Palliative (P) | 2017-04-09 | 2017-10-30 | Rituximab | N | N | 210023423 | RITUXIMAB |
| 210033138 | 210027168 | 1.81 | 67.2 | null | 2015-07-05 | 2015-07-14 | Rituximab | 02 | N | 210023453 | RITUXIMAB |
| 210033139 | 210010498 | null | null | Adjuvant (A) | null | 2015-08-13 | IBRUTINIB | 2 | N | 210023473 | IBRUTINIB |
| 210033140 | 210010520 | 1.8 | 45 | Adjuvant (A) | null | 2014-02-13 | Rituximab | N | N | 210023722 | RITUXIMAB |
| 210033141 | 210034954 | 1.57 | 52.7 | Palliative (P) | 2019-07-23 | 2019-07-23 | Lomustine | 02 | N | 210023729 | LOMUSTINE |
| 210033142 | 210027178 | 0 | 102 | Adjuvant (A) | 2018-01-07 | 2018-07-24 | Rituximab | N | N | 210023738 | RITUXIMAB |